Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Anderson, Kenneth
Item TypeName
Academic Article Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.
Academic Article Complete response to donor lymphocyte infusion in multiple myeloma is associated with antibody responses to highly expressed antigens.
Academic Article CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications.
Academic Article Multiple myeloma: how far have we come?
Academic Article Kidney disease associated with plasma cell dyscrasias.
Academic Article From the bench to the bedside: emerging new treatments in multiple myeloma.
Academic Article Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disorders.
Academic Article Multiple myeloma: biology of the disease.
Academic Article Advances in the treatment of monoclonal gammopaties: The emerging role of targeted therapy in plasma cell dyscrasias.
Academic Article The sumoylation pathway is dysregulated in multiple myeloma and is associated with adverse patient outcome.
Academic Article Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasias.
Academic Article Role of interleukin 16 in multiple myeloma pathogenesis: a potential novel therapeutic target?
Academic Article How I treat plasma cell leukemia.
Academic Article Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma.
Academic Article Proteomic analysis of waldenstrom macroglobulinemia.
Academic Article Potent in vitro and in vivo activity of an Fc-engineered humanized anti-HM1.24 antibody against multiple myeloma via augmented effector function.
Academic Article MGUS and smoldering myeloma: the most prevalent of plasma cell dyscrasias.
Academic Article The differentiation and stress response factor XBP-1 drives multiple myeloma pathogenesis.
Academic Article Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders.
Concept Leukemia, Plasma Cell
Concept Neoplasms, Plasma Cell
Concept Plasma Cells
Academic Article Targeting the bone marrow microenvironment in multiple myeloma.
Grant SPORE in Multiple Myeloma
Academic Article Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group.
Academic Article Multiple myeloma.
Academic Article Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma.
Academic Article Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1.
Academic Article Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma.
Academic Article International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders.
Academic Article Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
Academic Article miR-15a/16-1 deletion in activated B cells promotes plasma cell and mature B-cell neoplasms.
Search Criteria
  • Plasma Cells
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.